5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §102 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REZA, MOHAMMAD W | 1 | 87.6% | +10.9% |
| FIEBIG, RUSSELL G | 1 | 62.6% | +25.4% |
| HESTER, HOLLEY GRACE | 1 | 67.2% | +44.2% |
| MILLER, BETHANY MACKENZIE | 1 | 54.7% | +48.8% |
| EGWIM, KELECHI CHIDI | 1 | 69.9% | +13.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18735155 | ADVANCED CYBERSECURITY SYSTEMS FOR INFRASTRUCTURE AND NETWORK VULNERABILITY ANALYSIS | REZA, MOHAMMAD W | 57d |
| 18615593 | CURABLE SILOXANE-MODIFIED RESIN COMPOSITIONS WITH SILICONE-OIL ADDITIVES AND USE THEREOF | HESTER, HOLLEY GRACE | — |
| 18348866 | CURABLE COATING COMPOSITIONS HAVING SUPERHYDROPHOBIC, ANTI-ICING, AND ANTI-CORROSION PROPERTIES | MILLER, BETHANY MACKENZIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18051678 | BIO-BASED FURANIC DI(METH)ACRYLATES AS REACTIVE DILUENTS FOR UV CURABLE COATINGS | EGWIM, KELECHI CHIDI | 4d overdue |
| 18735155 | ADVANCED CYBERSECURITY SYSTEMS FOR INFRASTRUCTURE AND NETWORK VULNERABILITY ANALYSIS | REZA, MOHAMMAD W | 57d |
| 18640277 | PHENOLIC PHYTOCHEMICALS FOR BONE METASTASIS OF CANCER | FIEBIG, RUSSELL G | — |
| 18615593 | CURABLE SILOXANE-MODIFIED RESIN COMPOSITIONS WITH SILICONE-OIL ADDITIVES AND USE THEREOF | HESTER, HOLLEY GRACE | — |
| 18348866 | CURABLE COATING COMPOSITIONS HAVING SUPERHYDROPHOBIC, ANTI-ICING, AND ANTI-CORROSION PROPERTIES | MILLER, BETHANY MACKENZIE | — |
| Art Unit | Apps |
|---|---|
| 2407 | 1 |
| 1655 | 1 |
| 1766 | 1 |
| 1787 | 1 |
| 1762 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18735155 | ADVANCED CYBERSECURITY SYSTEMS FOR INFRASTRUCTURE AND NETWORK VULNERABILITY ANALYSIS | REZA, MOHAMMAD W | 2407 | §101§102 | Non-Final OA | 57d | Pending | Jun 05, 2024 |
| 18640277 | PHENOLIC PHYTOCHEMICALS FOR BONE METASTASIS OF CANCER | FIEBIG, RUSSELL G | 1655 | §103§112DP | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18615593 | CURABLE SILOXANE-MODIFIED RESIN COMPOSITIONS WITH SILICONE-OIL ADDITIVES AND USE THEREOF | HESTER, HOLLEY GRACE | 1766 | §102§103§112 | Non-Final OA | — | Pending | Mar 25, 2024 |
| 18348866 | CURABLE COATING COMPOSITIONS HAVING SUPERHYDROPHOBIC, ANTI-ICING, AND ANTI-CORROSION PROPERTIES | MILLER, BETHANY MACKENZIE | 1787 | §103§112 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18051678 | BIO-BASED FURANIC DI(METH)ACRYLATES AS REACTIVE DILUENTS FOR UV CURABLE COATINGS | EGWIM, KELECHI CHIDI | 1762 | §102 | Final Rejection | 4d overdue | Pending | Nov 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial